- Author:
Eun-Jung RHEE
1
Author Information
- Publication Type:Focused Issue
- From:Journal of Korean Diabetes 2020;21(1):11-20
- CountryRepublic of Korea
- Language:Korean
- Abstract: Treatment of diabetic dyslipidemia is important for prevention of cardiovascular disease in patients with diabetes. Although glucose control is the main target in patients with diabetes to prevent diabetic complications, multifactorial interventions are absolutely important in reducing risk for cardiovascular disease. Recent joint guidelines from European Society of Cardiology and European Society for the Study of Diabetes recommended lower low-density lipoprotein cholesterol (LDL-C) targets for patients with diabetes and included diabetes duration in the stratification of risk groups for cardiovascular disease prevention, emphasizing higher cardiovascular risk in patients with diabetes. In addition, American Heart Association/American College of Cardiology guidelines were revised in that the LDL-C cutoff actually appeared in the guidelines for high risk groups and for the change of treatment options. The Korean Diabetes Association released new treatment guidelines for patients with diabetes and adopted recent changes from other guidelines with respect to dyslipidemia control. In this review, I would like to review recent updates in guidelines regarding dyslipidemia treatment for patients with diabetes.